GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,538,000 | -11.7% | 21,954 | -18.8% | 0.32% | +39.0% |
Q4 2018 | $1,742,000 | +11.0% | 27,051 | +21.0% | 0.23% | +34.1% |
Q3 2018 | $1,570,000 | -11.5% | 22,357 | -36.5% | 0.17% | +11.8% |
Q2 2018 | $1,774,000 | +17.1% | 35,202 | -24.4% | 0.15% | +10.9% |
Q2 2017 | $1,515,000 | -0.3% | 46,551 | -3.5% | 0.14% | -17.5% |
Q1 2017 | $1,520,000 | -8.7% | 48,254 | -14.8% | 0.17% | -18.2% |
Q4 2016 | $1,664,000 | -13.5% | 56,603 | -14.9% | 0.20% | -3.3% |
Q3 2016 | $1,924,000 | +28.3% | 66,536 | +14.9% | 0.21% | +11.1% |
Q2 2016 | $1,500,000 | +31.3% | 57,893 | +25.6% | 0.19% | +20.4% |
Q1 2016 | $1,142,000 | +27.6% | 46,103 | +81.2% | 0.16% | -37.9% |
Q4 2015 | $895,000 | +294.3% | 25,438 | +137.1% | 0.25% | +256.3% |
Q3 2015 | $227,000 | -68.2% | 10,729 | -58.2% | 0.07% | -72.2% |
Q2 2015 | $713,000 | +33.3% | 25,649 | +46.5% | 0.26% | +22.0% |
Q1 2015 | $535,000 | +25.0% | 17,511 | +30.7% | 0.21% | +16.8% |
Q4 2014 | $428,000 | -11.0% | 13,400 | -23.6% | 0.18% | -29.5% |
Q2 2014 | $481,000 | -3.2% | 17,542 | +3.3% | 0.25% | +28.3% |
Q4 2013 | $497,000 | – | 16,984 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |